Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01581177Phase 2Completed
Phase 2, randomised, double-blind trial of albuterol dry powder inhaler in asthma (7 arms). Primary endpoint: Change in FEV1 Area Under the Curve versus placebo. Started Apr 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01581177.